Orient EuroPharma (OEP) acquires a stake in Quantum Genomics As a follow-up to the agreement signed last September, OEP acquired a minority stake in the capital of Quantum Genomics, thus strengthening the cooperation between the two companies. Read the press realease Previous Post (p) Quantum Genomics launches Phase III Pivotal REFRESH Study in Difficult-to-treat/Resistant Hypertension Next Post (n) Quantum Genomics Reports Full Year 2020 Operating and Financial Results